{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:12:15Z","timestamp":1783480335003,"version":"3.55.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007175","name":"Conseil National de la Recherche Scientifique","doi-asserted-by":"publisher","award":["BASF-BCS"],"award-info":[{"award-number":["BASF-BCS"]}],"id":[{"id":"10.13039\/501100007175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epigenet. Epigenom."],"abstract":"<jats:p>Histone deacetylases (HDACs) are key epigenetic regulators that catalyze the removal of acetyl groups from histones and non-histone proteins, thereby modulating chromatin accessibility and gene expression. The HDAC family is composed of 11 HDACs and seven sirtuins that are all located within the epidermis. These enzymes are involved in essential cellular processes such as proliferation, differentiation, the regulation of immune function and wound healing, thus playing a central role in maintaining tissue homeostasis. This review aims to explore the mechanistic contributions of HDACs to epidermis physiology and investigate their involvement in the development of diseases such as psoriasis, atopic dermatitis and cancers. It also highlights the therapeutic potential of HDAC inhibitors, which are already used in oncology but whose application in dermatology is still emerging.<\/jats:p>","DOI":"10.3389\/freae.2025.1711733","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:30:06Z","timestamp":1765175406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Histones deacetylases in the epidermis: structure, functions and therapeutic implications"],"prefix":"10.3389","volume":"3","author":[{"given":"Chlo\u00e9","family":"Nguyen Van","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Lamartine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","article-title":"IDO activates regulatory T cells and blocks their conversion into Th17-Like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/jcmm.12345","article-title":"HDAC \u2010Inhibitor (S)\u20108 disrupts HDAC 6\u2010 PP 1 complex prompting A375 melanoma cell growth arrest and apoptosis","volume":"19","author":"Balliu","year":"2015","journal-title":"J. Cell. Mol. Medi"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"26694","DOI":"10.1074\/jbc.M803514200","article-title":"Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain","volume":"283","author":"Bottomley","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12967-019-1998-9","article-title":"The epigenome as a putative target for skin repair: the HDAC inhibitor trichostatin A modulates myeloid progenitor plasticity and behavior and improves wound healing","volume":"17","author":"Cabanel","year":"2019","journal-title":"J. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/molecules30153224","article-title":"A novel HDAC6 inhibitor ameliorates imiquimod-induced psoriasis-like inflammation in mice","volume":"30","author":"Cao","year":"2025","journal-title":"Molecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/biomedicines10081994","article-title":"The histone deacetylase inhibitor ITF2357 (givinostat) targets oncogenic BRAF in melanoma cells and promotes a switch from pro-survival autophagy to apoptosis","volume":"10","author":"Celesia","year":"2022","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E2865","DOI":"10.1073\/pnas.1121131109","article-title":"Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages","volume":"109","author":"Chen","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"BSR20210462","DOI":"10.1042\/BSR20210462","article-title":"Histone deacetylase 10, a potential epigenetic target for therapy","volume":"41","author":"Cheng","year":"2021","journal-title":"Biosci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/genes14061295","article-title":"Histone deacetylases (HDAC) inhibitor\u2014valproic acid sensitizes human melanoma cells to dacarbazine and PARP inhibitor","volume":"14","author":"Drzewiecka","year":"2023","journal-title":"Genes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Investigational Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood.V112.11.1005.1005","article-title":"Phase II trial of oral panobinostat (LBH589) in patients with refractory cutaneous T-Cell lymphoma (CTCL)","volume":"112","author":"Duvic","year":"2008","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1034\/j.1600-0625.2002.110503.x","article-title":"Evidence for local control of gene expression in the epidermal differentiation complex","volume":"11","author":"Elder","year":"2002","journal-title":"Exp. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/43710","article-title":"Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors","volume":"401","author":"Finnin","year":"1999","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/89668","article-title":"Structure of the histone deacetylase SIRT2","author":"Finnin","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"25748","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/ijms20051110","article-title":"Regulation of chemokines and cytokines by histone deacetylases and an update on histone decetylase inhibitors in human diseases","volume":"20","author":"Gatla","year":"2019","journal-title":"IJMS"},{"key":"B19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","article-title":"Skin cancer: an overview of epidemiology and risk factors","volume":"29","author":"Gordon","year":"2013","journal-title":"Seminars Oncol. Nurs."},{"key":"B20","doi-asserted-by":"publisher","first-page":"111396","DOI":"10.1016\/j.celrep.2022.111396","article-title":"Targeting the USP7\/RRM2 axis drives senescence and sensitizes melanoma cells to HDAC\/LSD1 inhibitors","volume":"40","author":"Granieri","year":"2022","journal-title":"Cell Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J. Mol. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e13731","DOI":"10.1111\/cpr.13731","article-title":"HDAC3 in action: expanding roles in inflammation and inflammatory diseases","volume":"58","author":"He","year":"2025","journal-title":"Cell Prolif."},{"key":"B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/ijms23020849","article-title":"HDAC2 is involved in the regulation of BRN3A in melanocytes and melanoma","volume":"23","author":"Heppt","year":"2022","journal-title":"IJMS"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/exd.13089","article-title":"Inhibition of histone deacetylases in Melanoma\u2014A perspective from bench to bedside","volume":"25","author":"Hornig","year":"2016","journal-title":"Exp. Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.2147\/CMAR.S284199","article-title":"Upregulated histone deacetylase 6 associates with malignant progression of melanoma and predicts the prognosis of patients","volume":"12","author":"Hu","year":"2020","journal-title":"CMAR"},{"key":"B30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jid.2013.283","article-title":"Disrupted ectodermal organ morphogenesis in mice with a conditional histone deacetylase 1, 2 deletion in the Epidermis","volume":"134","author":"Hughes","year":"2014","journal-title":"J. Investigative Dermatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2023.05.001","article-title":"Topical histone deacetylase 1 inhibitor entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response","volume":"110","author":"Jiang","year":"2023","journal-title":"J. Dermatological Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"177011","DOI":"10.1016\/j.ejphar.2024.177011","article-title":"Topical histone deacetylase inhibitor remetinostat improves IMQ-Induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation","volume":"983","author":"Jin","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1038\/jid.2011.139","article-title":"Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-Producing cells and are found in lesional skin","volume":"131","author":"Jorn Bovenschen","year":"2011","journal-title":"J. Investigative Dermatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.3390\/jcm10173880","article-title":"The defect in regulatory T cells in psoriasis and therapeutic approaches","volume":"10","author":"Kanda","year":"2021","journal-title":"JCM"},{"key":"B35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/exd.13872","article-title":"Epigenetic control in skin development, homeostasis and injury repair","volume":"28","author":"Kang","year":"2019","journal-title":"Exp. Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4093\/dmj.2023.0174","article-title":"Roles of histone deacetylase 4 in the inflammatory and metabolic processes","volume":"48","author":"Kang","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"165903","DOI":"10.1016\/j.bbadis.2020.165903","article-title":"HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1\u03b2 secretion in diabetic mice","volume":"1866","author":"Karnam","year":"2020","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/cancers11050673","article-title":"SIRT2 contributes to the resistance of melanoma cells to the multikinase inhibitor dasatinib","volume":"11","author":"Karwaciak","year":"2019","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/cancers15041123","article-title":"HDAC8 deacetylates HIF-1\u03b1 and enhances its protein stability to promote tumor growth and migration in melanoma","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17\u2013producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1021\/acschembio.7b00942","article-title":"Histone deacetylase 11 is a fatty-acid deacylase","volume":"13","author":"Kutil","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","article-title":"Panobinostat for the treatment of multiple myeloma","volume":"21","author":"Laubach","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.devcel.2010.10.015","article-title":"Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells","volume":"19","author":"LeBoeuf","year":"2010","journal-title":"Dev. Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA approval: Belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/bjd.14878","article-title":"Interferon\u2010inducible T\u2010cell alpha chemoattractant (ITAC) induces the melanocytic migration and hypopigmentation through destabilizing p53 via histone deacetylase 5: a possible role of ITAC in pigment\u2010related disorders","volume":"176","author":"Lee","year":"2017","journal-title":"Br. J. Dermatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/epigenomes8010009","article-title":"Dynamics and epigenetics of the epidermal differentiation complex","volume":"8","author":"Le\u015bniak","year":"2024","journal-title":"Epigenomes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/ijms20071616","article-title":"Mechanism of action for HDAC inhibitors\u2014insights from omics approaches","volume":"20","author":"Li","year":"2019","journal-title":"IJMS"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/690901","article-title":"Regulation of immune responses by histone deacetylase inhibitors","volume":"2012","author":"Licciardi","year":"","journal-title":"ISRN Hematol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.molonc.2015.12.012","article-title":"Essential role of HDAC6 in the regulation of PD\u2010L1 in melanoma","volume":"10","author":"Lienlaf","year":"2016","journal-title":"Mol. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jaci.2020.02.007","article-title":"Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335:SOX6 axis","volume":"146","author":"Liew","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12967-015-0753-0","article-title":"Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells","volume":"14","author":"Liu","year":"2016","journal-title":"J. Transl. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"29168","DOI":"10.1074\/jbc.M112.371120","article-title":"Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"115418","DOI":"10.1016\/j.biopha.2023.115418","article-title":"HDAC11: a novel target for improved cancer therapy","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed. and Pharmacother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1021\/jm301254q","article-title":"Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells","volume":"56","author":"Marek","year":"2013","journal-title":"J. Med. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"832047","DOI":"10.3389\/fonc.2022.832047","article-title":"The role of histone post-translational modifications in merkel cell carcinoma","volume":"12","author":"Mazziotta","year":"2022","journal-title":"Front. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"404","DOI":"10.18632\/oncotarget.26552","article-title":"Transducin-like enhancer of split 3 regulates proliferation of melanoma cells via histone deacetylase activity","volume":"10","author":"Ogawa","year":"2019","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1021\/acs.biochem.9b00934","article-title":"Structural basis of catalysis and inhibition of HDAC6 CD1, the enigmatic catalytic domain of histone deacetylase 6","volume":"58","author":"Osko","year":"2019","journal-title":"Biochemistry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.3390\/ijms23073660","article-title":"Histone deacetylase (HDAC) inhibitors: a promising weapon to tackle therapy resistance in melanoma","volume":"23","author":"Palamaris","year":"2022","journal-title":"IJMS"},{"key":"B60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jdermsci.2011.11.009","article-title":"Histone deacetylase activity is required for skin langerhans cell maturation and phagocytosis","volume":"65","author":"Qi","year":"2012","journal-title":"J. Dermatological Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e20212397","DOI":"10.1084\/jem.20212397","article-title":"A dysregulated sebum\u2013microbial metabolite\u2013IL-33 axis initiates skin inflammation in atopic dermatitis","volume":"219","author":"Qiu","year":"2022","journal-title":"J. Exp. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e2502047","DOI":"10.4014\/jmb.2502.02047","article-title":"Effect of particulate matter in atopic dermatitis through HDACs and filaggrin alteration","volume":"35","author":"Roh","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"14551","DOI":"10.3390\/ijms241914551","article-title":"Histone and histone acetylation-related alterations of gene expression in uninvolved psoriatic skin and their effects on cell proliferation, differentiation, and immune responses","volume":"24","author":"Romh\u00e1nyi","year":"2023","journal-title":"IJMS"},{"key":"B64","doi-asserted-by":"publisher","first-page":"109489","DOI":"10.1016\/j.abb.2022.109489","article-title":"Anti-proliferative, pro-apototic and anti-migratory properties of HDAC inhibitor PXD-101 on osteosarcoma cell lines","volume":"734","author":"Rossi","year":"2023","journal-title":"Archives Biochem. Biophysics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/CMR.0000000000000926","article-title":"Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies","volume":"33","author":"Rubatto","year":"2023","journal-title":"Melanoma Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem. J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3892\/ijo.29.1.117","article-title":"Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma","volume":"29","author":"Sakuma","year":"2006","journal-title":"Int. J. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/exd.14502","article-title":"Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis","volume":"31","author":"Samuelov","year":"2022","journal-title":"Exp. Dermatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbapap.2009.09.009","article-title":"Structural basis for sirtuin function: what we know and what we don\u2019t","volume":"1804","author":"Sanders","year":"2010","journal-title":"Biochimica Biophysica Acta (BBA) - Proteins Proteomics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"eaah4609","DOI":"10.1126\/sciimmunol.aah4609","article-title":"Inhibition of HDAC8 and HDAC9 by microbial short-chain fatty acids breaks immune tolerance of the Epidermis to TLR ligands","volume":"1","author":"Sanford","year":"2016","journal-title":"Sci. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.4049\/jimmunol.1800893","article-title":"Short-chain fatty acids from Cutibacterium acnes activate both a canonical and epigenetic inflammatory response in human sebocytes","volume":"202","author":"Sanford","year":"2019","journal-title":"J. Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/15592294.2014.1003746","article-title":"Epigenetic regulation in human melanoma: past and future","volume":"10","author":"Sarkar","year":"2015","journal-title":"Epigenetics"},{"key":"B73","first-page":"399","article-title":"Histone deacetylase inhibitors as potential anti-skin cancer agents","volume":"59","author":"Saunders","year":"1999","journal-title":"Cancer Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"eabe1935","DOI":"10.1126\/sciimmunol.abe1935","article-title":"Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8\/9","volume":"6","author":"Sawada","year":"2021","journal-title":"Sci. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"key":"B77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/978-1-4020-6554-5_13","article-title":"Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis","volume-title":"Programmed cell death in cancer progression and therapy","author":"Shankar","year":"2008"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/ijms18071360","article-title":"The Co-Expression pattern of p63 and HDAC1: a potential way to disclose stem cells in interfollicular epidermis","volume":"18","author":"Shin","year":"2017","journal-title":"IJMS"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"Somoza","year":"2004","journal-title":"Structure"},{"key":"B80","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jid.2020.08.023","article-title":"The HDAC inhibitor domatinostat promotes cell-cycle arrest, induces apoptosis, and increases immunogenicity of merkel cell carcinoma cells","volume":"141","author":"Song","year":"2021","journal-title":"J. Investigative Dermatology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"11004","DOI":"10.1074\/jbc.M112.441816","article-title":"A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair","volume":"288","author":"Spallotta","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.3390\/ijms22084130","article-title":"Molecular mechanisms of atopic dermatitis pathogenesis","volume":"22","author":"Sroka-Tomaszewska","year":"2021","journal-title":"IJMS"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.4049\/jimmunol.0804388","article-title":"Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3","volume":"182","author":"Sun","year":"2009","journal-title":"J. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/ijms26020438","article-title":"Epigenetic regulatory processes involved in the establishment and maintenance of skin homeostasis\u2014the role of microbiota","volume":"26","author":"Szab\u00f3","year":"2025","journal-title":"IJMS"},{"key":"B85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1101\/gad.333674.119","article-title":"HDAC3 ensures stepwise epidermal stratification via NCoR\/SMRT-reliant mechanisms independent of its histone deacetylase activity","volume":"34","author":"Szigety","year":"2020","journal-title":"Genes Dev."},{"key":"B86","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.272.5260.408","article-title":"A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p","volume":"272","author":"Taunton","year":"1996","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-4632.2006.02962.x","article-title":"Under\u2010expression of VHL and over\u2010expression of HDAC\u20101, HIF\u20101\u03b1, LL\u201037, and IAP\u20102 in affected skin biopsies of patients with psoriasis","volume":"46","author":"Tovar\u2010Castillo","year":"2007","journal-title":"Int. J. Dermatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jaci.2014.10.002","article-title":"Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation","volume":"135","author":"Tsuji","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1007\/s13277-014-2098-3","article-title":"Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin","volume":"35","author":"Uzdensky","year":"2014","journal-title":"Tumor Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/ijms21072356","article-title":"Histone deacetylation inhibitors as modulators of regulatory T cells","volume":"21","author":"Von Knethen","year":"2020","journal-title":"IJMS"},{"key":"B92","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0002-9440(10)63320-2","article-title":"Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues","volume":"165","author":"Waltregny","year":"2004","journal-title":"Am. J. Pathology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1419685","DOI":"10.3389\/fimmu.2024.1419685","article-title":"The role of HDAC3 in inflammation: mechanisms and therapeutic implications","volume":"15","author":"Watson","year":"2024","journal-title":"Front. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.3390\/cancers13184700","article-title":"Vorinostat (SAHA) and breast cancer: an overview","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers"},{"key":"B95","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.exger.2009.10.001","article-title":"Role of HDAC1 in senescence, aging, and cancer","volume":"45","author":"Willis-Martinez","year":"2010","journal-title":"Exp. Gerontol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1038\/emboj.2013.243","article-title":"Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis: HDAC1 negatively controls epidermal proliferation","volume":"32","author":"Winter","year":"2013","journal-title":"EMBO J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.molonc.2015.04.002","article-title":"Targeting histone deacetylase 6 mediates a dual anti\u2010melanoma effect: enhanced antitumor immunity and impaired cell proliferation","volume":"9","author":"Woan","year":"2015","journal-title":"Mol. Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","article-title":"The sirtuin family in health and disease","volume":"7","author":"Wu","year":"2022","journal-title":"Sig Transduct. Target Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"102580","DOI":"10.1016\/j.coi.2025.102580","article-title":"Epigenetic regulation in vitiligo: mechanisms, challenges, and therapeutic opportunities","volume":"95","author":"Wu","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/ijc.29979","article-title":"HDAC5 controls the functions of Foxp3+ T\u2010regulatory and CD8+ T cells","volume":"138","author":"Xiao","year":"2016","journal-title":"Intl J. Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/cvr\/cvy051","article-title":"HDAC4 regulates vascular inflammation via activation of autophagy","volume":"114","author":"Yang","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","article-title":"Potent and specific inhibition of Mammalian histone deacetylase both in vivo and in vitro by trichostatin A","volume":"265","author":"Yoshida","year":"1990","journal-title":"J. Biol. Chem."},{"key":"B104","doi-asserted-by":"publisher","first-page":"108346","DOI":"10.4239\/wjd.v16.i10.108346","article-title":"Potential roles of histone deacetylases in diabetic wound healing","volume":"16","author":"Zhang","year":"2025","journal-title":"World J. Diabetes"},{"key":"B105","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s12967-025-06544-w","article-title":"Inhibition of histone deacetylases 3 attenuates imiquimod-induced psoriatic dermatitis via targeting cGAS-STING signaling in keratinocytes","volume":"23","author":"Zeng","year":"2025","journal-title":"J. Transl. Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"117295","DOI":"10.1016\/j.biopha.2024.117295","article-title":"Histone deacetylases and their inhibitors in inflammatory diseases","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed. and Pharmacother."},{"key":"B107","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jid.2021.05.026","article-title":"HDAC1\/2 control proliferation and survival in adult epidermis and pre\u2012basal cell carcinoma through p16 and p53","volume":"142","author":"Zhu","year":"2022","journal-title":"J. Investigative Dermatology"}],"container-title":["Frontiers in Epigenetics and Epigenomics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/freae.2025.1711733\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:30:08Z","timestamp":1765175408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/freae.2025.1711733\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":107,"alternative-id":["10.3389\/freae.2025.1711733"],"URL":"https:\/\/doi.org\/10.3389\/freae.2025.1711733","relation":{},"ISSN":["2813-706X"],"issn-type":[{"value":"2813-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"article-number":"1711733"}}